MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility ...

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology ...

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its ...

Lifeward had a second executive join its C-suite transition in two months as the Marlborough-based medical device has selected its new CFO. Lifeward mobility products will be available in six new ...

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest ...

ReWalk Robotics Ltd. misses on earnings expectations. Reported EPS is $-0.58 EPS, expectations were $-0.25. Operator: Good day, and welcome to the Second Quarter 2025 Lifeward Conference Call.

Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ...

ReWalk Robotics Ltd. (Nasdaq: RWLK), the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the ...

Reynolds’s exoskeleton technology, called the ReWalk 7, helps her stand and walk by propelling her forward. Medicare has ...

Lifeward (LFWD) announced that it received prior authorization from Humana Medicare Advantage Plan for a ReWalk 7 Personal Exoskeleton. This marks the second national Medicare Advantage Plan, ...

“Nationally nearly half of all Medicare Advantage enrollees are now eligible for prior authorization and reimbursement for ReWalk 7,” said Mark Grant, CEO of Lifeward. “This prior authorization ...